Skip to main navigation
Our Science
AT-527
COVID-19
About Atea
About Us
Pipelines & Programs
Leadership
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Careers
Contact
Investor Relations
DEF 14A
Breadcrumb
Investors
DEF 14A
> Back to SEC
Go Back
SEC Filing Details
Form
DEF 14A
Filing Date
April 28, 2023
Document Date
April 28, 2023
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filing Formats
View HTML
Download PDF
Download DOC
Download XLS
XBRL
XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
Investor FAQs
RSS Feeds
Email Alerts
Contact IR